MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.250
+0.010 (0.81%)
At close: Apr 28, 2026, 4:00 PM EDT
1.250
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:08 AM EDT
MAIA Biotechnology Employees
MAIA Biotechnology had 13 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,722,782
Market Cap
75.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13 | 0 | - |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | -5 | -27.78% |
| Dec 31, 2022 | 18 | 9 | 100.00% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 142 |
| Pelthos Therapeutics | 92 |
| XBiotech | 85 |
| ImmuCell | 73 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
MAIA News
- 20 days ago - MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy - GlobeNewsWire
- 4 weeks ago - MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer - GlobeNewsWire
- 4 weeks ago - Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) - GlobeNewsWire
- 7 weeks ago - MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - MAIA Biotechnology's Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market - GlobeNewsWire
- 3 months ago - MAIA Biotechnology Advances Ateganosine Cancer Treatment Program, Outlines Targeted 2026 Clinical Milestones and Growth Momentum - GlobeNewsWire
- 4 months ago - MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings - GlobeNewsWire